I work closely with patients to prevent vision loss from this or other eye diseases. Current advances include many non-invasive procedures that can help.
As a young physician, I completed my ophthalmology residency under the direction of the distinguished Dr. William Havener. He was the first full-time ophthalmologist at The Ohio State University College of Medicine and Public Health. He was chair of the Department of Ophthalmology at the young age of 35.
The late Dr. Havener's high standards still influence me and prevail here at his namesake, the Havener Eye Institute. His legacy as a compassionate physician, a skilled surgeon, an internationally known author and innovative leader are all part of our institute's great history.
It's a privilege to carry on those standards, alongside my expert colleagues at Ohio State. We are dedicated to providing outstanding care and service. From personalized office visits to skilled surgical procedures, our patients are in good hands.
- Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2014, 2015, 2016
- Presenter, Association for Research and Vision in Ophthalmology (ARVO)
- Coordinator, Grand Rounds for physicians, students and faculty
University of Michigan Medical School
Ohio State University Wexner Medical Ctr
1/1/1958 - 1/1/1961
Specialties and conditions I treat
Locations where I practice
More about my work
American Board of Ophthalmology
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/25/2016, Dr. Kapetansky has reported no financial relationships with medical device, research and/or drug companies.